Alicia Probst
Papers
2
Total Citations
36
H-Index
2
About
Alicia Probst is a leading gynecologic oncologist and researcher whose work centers on improving surgical outcomes for women with gynecologic cancers. Her primary research areas include minimally invasive surgery, perioperative morbidity, and the comparative effectiveness of robot-assisted versus conventional laparoscopy. Dr. Probst’s most significant contribution is her leadership of the landmark ROBOGYN-1004 trial, a randomized study that provided critical evidence on severe perioperative morbidity in gynecologic oncology surgery. Her 2020 publication of the trial’s primary results, which has garnered 34 citations, directly compared robot-assisted and conventional laparoscopy, offering surgeons and patients data-driven insights into surgical risks. In a subsequent 2024 secondary analysis, Dr. Probst further advanced the field by identifying how surgical complexity and center experience influence postoperative complications, providing actionable lessons for optimizing care. Her work has shaped clinical guidelines and informed surgical decision-making, helping to reduce patient harm. Dr. Probst’s rigorous, evidence-based approach continues to drive improvements in surgical safety and quality in gynecologic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2